EMR
Loading…
PREV CLOSE OPEN DAY RANGE
Analyzing 0%
MASTER
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence
Data coverage
ESEN NEWS INTELLIGENCE — EMR
Sentiment: Mixed Impact: Medium

Emerson Electric reported strong Q3 2026 results with raised full-year EPS guidance to $6.55, demonstrating solid operational execution in core automation. The company secured a multi-million-dollar BP contract for Shah Deniz Compression automation technologies, reinforcing market leadership. However, recent insider selling by President & CEO Surendralal Lanca ($1.56M on August 12) and analyst commentary suggest valuation concerns despite 79.2% three-year returns. Forward PE of 21.1x reflects normalization from prior bargain levels, with hyper-growth flags offset by modest EPS decline YoY (-1.79%) and elevated current PE (39.3x).

Current Price
$163.90
Forward P/E
21.1x
Dividend Yield
1.35%
52W Return
21.6%
Recent Material Events
Date Event Tone
Aug 12 CEO Surendralal Lanca sold $1.56M of EMR stock per SEC filing Cautionary
Aug 8 BP awards multi-million-dollar automation contract for Shah Deniz Compression project Positive
Aug 7 Q3 2026 earnings: raised full-year EPS guidance to $6.55; strong operational execution Positive
Aug 6 Analyst commentary: valuation near fair value despite raised guidance and AI investments Neutral
Compliance Note: This summary reflects publicly available news as of August 14, 2026. Insider transactions are reported via SEC filings. Forward guidance and earnings dates subject to company disclosure schedule. No price targets or investment recommendations provided.
SNAPSHOT
Ticker
EMR
Company
Emerson Electric Co
Sector
Electrical Equipment
Market Cap
$90.2B
Price
$163.90
52W Range
$122.64 – $166.35
52W Return
+21.64%
Dividend Yield
1.35%
EARNINGS MOMENTUM (HIGH PRIORITY)
⚠ Data Constraint: Earnings history (last 4 quarters actuals, estimates, surprises) not available in current dataset. Earnings date not disclosed. Assessment based on YoY growth metrics and forward guidance proxies.
Metric Value Assessment
EPS (TTM) $4.57 Current earnings power
EPS Growth YoY -1.79% Contraction – earnings declining YoY
Revenue Growth YoY +4.82% Modest organic growth
Forward P/E 21.06x Forward multiple suggests margin recovery expected
Trailing P/E 39.32x Stretched valuation on depressed earnings base
Earnings Momentum Analysis:
EMR shows contradictory signals. Revenue growth of +4.8% YoY is solid, yet EPS contracted -1.79% YoY, indicating margin compression or higher share count. The forward P/E of 21.1x is substantially lower than trailing 39.3x, suggesting markets expect material earnings recovery ahead. However, without current quarter guidance or earnings dates, upside confidence is constrained.
📊 Earnings Momentum Score: 3/10 | Direction: Headwind (margin pressure despite revenue growth)
PROFITABILITY & QUALITY
⚠ Data Constraint: Gross margin, operating margin, net margin, ROE, ROIC, and FCF not disclosed in current dataset. Assessment is limited to available profitability proxies.
Metric Value Status
EPS (TTM) $4.57 Modest earnings generation
Dividend Per Share $2.10 Sustainable (DPS/EPS = 46% payout)
Dividend Yield 1.35% Below-market yield; modest income
Gross/Operating/Net Margins Not Disclosed Coverage constrained
Free Cash Flow (TTM) Not Disclosed FCF trend unavailable
Flag: Strong Profitability? NO System flag indicates weak profitability profile
Quality Assessment:
EMR shows mixed quality signals. A 46% dividend payout ratio is conservative and sustainable, suggesting management confidence in cash generation. However, the system flagged "strong_profitability: false," and detailed margin/ROE/FCF data are not available. The contraction in EPS despite revenue growth indicates operational or cost headwinds that limit quality confidence. Without visibility into cash generation or return ratios, quality assessment is constrained.
💡 Quality Score: 4/10 | Verdict: Weak – Margin pressure, limited profitability transparency
BALANCE SHEET HEALTH
⚠ Data Constraint: Cash, total debt, equity, current ratio, and debt ratios not disclosed in current dataset. Balance sheet assessment is limited.
Metric Value Status
Cash & Equivalents Not Disclosed Liquidity visibility constrained
Total Debt Not Disclosed Leverage profile unknown
Net Debt / EBITDA Not Disclosed Debt capacity unavailable
Current Ratio Not Disclosed Short-term liquidity unknown
Weak Balance Sheet Flag? NO System does not flag balance weakness
Market Cap / Enterprise Value $90.2B Large-cap stability (EV ≈ Market Cap implies low net debt)
Balance Sheet Inference:
Detailed balance sheet metrics are not available. However, the system flag "weak_balance: false" and the fact that enterprise value ≈ market cap suggest EMR is not highly leveraged. Large-cap industrial companies like Emerson typically maintain investment-grade balance sheets. The lack of explicit weakness flags is reassuring, but full debt/liquidity transparency is needed for definitive assessment.
🏦 Balance Sheet Risk: Moderate | Verdict: No Explicit Red Flags, but Limited Transparency
VALUATION ANALYSIS
Metric Value Assessment
Trailing P/E (TTM) 39.32x Expensive. Well above industrial/equipment median (~18-22x)
Forward P/E (FY1) 21.06x Fair to slightly elevated on normalized earnings
PEG Ratio -21.97 Negative (EPS declining); PEG not meaningful
Price / Sales Not Disclosed Revenue data unavailable for P/S calc
Price / FCF Not Disclosed FCF data not available
EV / EBITDA Not Disclosed EBITDA data not available
High Valuation Flag? NO System does not flag valuation as extreme
Valuation Spread (Trailing vs Forward) 18.26x gap Wide gap; market expects significant earnings recovery

EMR Stock AI Analysis

ESEN AI analysis of EMR stock updated every 12 hours.

ESEN Institutional Analysis

EMR Systematic Research

Emerson Electric presents a distinctive profile among electrical equipment manufacturers, with systematic screening highlighting a premium valuation framework supported by substantial profitability margins. The company's P/E ratio of 34.29 trades at a significant premium to industrial sector averages, while the net margin of 13.34% and gross margin of 52.66% demonstrate pricing power and operational efficiency in its automation and climate technologies segments. The current price of $149.82 positions EMR approximately 9% below its 52-week high of $165.15, reflecting recent consolidation in a long-term uptrend.

The fundamental model reveals several strengths worth noting:

  • Margin excellence: The operating margin of 19.33% reflects disciplined cost management and value-added positioning in industrial automation markets
  • Moderate leverage: The debt-to-equity ratio of 0.65 provides financial flexibility while maintaining tax-efficient capital structure
  • Profitability metrics: ROE of 12.11% demonstrates reasonable shareholder return generation relative to book value per share of $36.04

Research perspective identifies concerns around the current ratio of 0.88, which flags potential near-term liquidity constraints requiring monitoring. Additionally, the revenue growth of 4.03% and EPS growth of 3.35% year-over-year represent modest expansion rates relative to the elevated valuation multiple, suggesting market pricing anticipates acceleration from current levels.

Relative to peers including AMETEK (AME) and Vertiv (VRT), Emerson's market capitalization of $83.9 billion establishes it as a large-cap anchor within the electrical equipment sector, with beta of 1.24 indicating slightly elevated market sensitivity compared to diversified industrials.

Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.